This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Shihab-Eldeen, A. Articles by Yacoub, T. Search for Related Content PubMed PubMed Citation Articles by Shihab-Eldeen, A. Articles by Yacoub, T. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CYCLOSPORIN A Social Bookmarking                         What's this?

Experimental studies on multiorgan toxicity of cyclosporine-A in rats using a radiopharmaceutical and comparison with histopathological findings

Department of Pharmacology and Toxicology, Kuwait University

A. Owunwanne

Nuclear Medicine, Kuwait University

TA Junaid

Pathology, Faculty of Medicine, Kuwait University, Kuwait

T. Yacoub

Nuclear Medicine, Kuwait University

Iodine-125 HIPDM was evaluated as a screening agent for studying multiorgan toxicity due to Cyclosporine-A (CsA) and the results were compared to histopathological findings of the tissues. The rats were injected subcuta neously with 50 mg/kg (body weight) of CsA or with equal volume of the vehicle, Cremophor-EL, for 7 consecutive days. A dose of 10 µCi of I-125 HIPDM was injected intravenously at the end of the treatment period. The results indicated that there was a significant increase in the uptake of 1-125 HIPDM in the kidney, liver, heart and blood compared to control rats (P < 0.05). However, there was a significant decrease in the uptake of 1-125 HIPDM in the spleen compared to control animals (P < 0.001). The lung and brain of CsA treated rats showed no change in the uptake of I-125 HIPDM when compared to control rats.

The change in the uptake of I-125 HIPDM in these organs was assumed to indicate tissue response to the toxic effects of CsA. The radiopharmaceutical results were compar able with the histopathological findings in which the organs showed varying degrees of tissue degeneration. It is concluded that the lipophilic radiopharmaceutical, 1-125 HIPDM, can be used as an effective screening agent to study multiorgan toxicity due to CsA.

Key Words: cyclosporine-A • multiorgan toxicity • radiopharmaceu tical • 1-125 HIPDM • histopathology • rats

Human & Experimental Toxicology, Vol. 15, No. 11, 867-871 (1996)
DOI: 10.1177/096032719601501101


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?